Literature DB >> 31356947

Cellular uptake and transport characteristics of chitosan modified nanoparticles in Caco-2 cell monolayers.

Taoyan Dou1, Jie Wang1, Chengkun Han1, Xiaowei Shao1, Jie Zhang1, Wen Lu2.   

Abstract

The bioadhesive drug delivery systems, chitosan modified nanoparticles, can efficiently adhere to mucosal surface of gastrointestinal tract and prolong residence time but a deeper understanding about its cellular uptake and transport is still lack. Hence, the present study was designed to compare the process of uptake and transport between chitosan modified and unmodified PLGA nanoparticles. Chitosan modified nanoparticles were formulated by classic and chemical methods. The morphology and modification potency were characterized by zeta potential, FTIR, DSC, XPS and TEM. Coumarin-6 load chitosan modified nanoparticles were incubated with Caco-2 cells to study the process of uptake and transport. The kinetic of cellular uptake for chitosan modified and unmodified nanoparticles was time- and concentration-dependent endocytosis but the cellular uptake efficiency of modified nanoparticles was significantly higher than that of unmodified one within the high concentration range (25.0-100.0 μg/mL). The modified nanoparticles underwent clathrin-mediated endocytosis and macropinocytosis but unmodified nanoparticles occurred a clathrin-mediated endocytosis. Both types of nanoparticles can increase caulophine with low solubility and poor stability transmembrane transport and the modified nanoparticles exhibited a better transcellular permeability. Therefore, the chitosan modified nanoparticles showed significantly improved cellular uptake and transcellular transport and a potential improvement in the efficacy of oral drug delivery.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cellular uptake; Nanoparticles; Transcellular transport

Mesh:

Substances:

Year:  2019        PMID: 31356947     DOI: 10.1016/j.ijbiomac.2019.07.168

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  8 in total

1.  Investigation of the Uptake and Transport of Aspirin Eugenol Ester in the Caco-2 Cell Model.

Authors:  Qi Tao; Zhe Qin; Xi-Wang Liu; Zhen-Dong Zhang; Shi-Hong Li; Li-Xia Bai; Jian-Yong Li; Ya-Jun Yang
Journal:  Front Pharmacol       Date:  2022-05-04       Impact factor: 5.988

Review 2.  Endocytosis: The Nanoparticle and Submicron Nanocompounds Gateway into the Cell.

Authors:  Darío Manzanares; Valentín Ceña
Journal:  Pharmaceutics       Date:  2020-04-17       Impact factor: 6.321

3.  Garcinol Encapsulated Ph-Sensitive Biodegradable Nanoparticles: A Novel Therapeutic Strategy for the Treatment of Inflammatory Bowel Disease.

Authors:  Eden Mariam Jacob; Ankita Borah; Sindhu C Pillai; D Sakthi Kumar
Journal:  Polymers (Basel)       Date:  2021-03-11       Impact factor: 4.329

Review 4.  Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment.

Authors:  Hazem Choukaife; Salma Seyam; Batoul Alallam; Abd Almonem Doolaanea; Mulham Alfatama
Journal:  Int J Nanomedicine       Date:  2022-09-07

5.  Preparation of a pH-responsive chitosan-montmorillonite-nitrogen-doped carbon quantum dots nanocarrier for attenuating doxorubicin limitations in cancer therapy.

Authors:  Erfan Rahmani; Mehrab Pourmadadi; Sohrab Ali Ghorbanian; Fatemeh Yazdian; Hamid Rashedi; Mona Navaee
Journal:  Eng Life Sci       Date:  2022-09-13       Impact factor: 3.405

6.  Oral delivery of metformin by chitosan nanoparticles for polycystic kidney disease.

Authors:  Jonathan Wang; Deborah Chin; Christopher Poon; Valeria Mancino; Jessica Pham; Hui Li; Pei-Yin Ho; Kenneth R Hallows; Eun Ji Chung
Journal:  J Control Release       Date:  2020-10-28       Impact factor: 9.776

7.  Preparation and characterization of paclitaxel palmitate albumin nanoparticles with high loading efficacy: an in vitro and in vivo anti-tumor study in mouse models.

Authors:  Hang Chen; Sifan Huang; Heyi Wang; Xinmei Chen; Haiyan Zhang; Youfa Xu; Wei Fan; Yun Pan; Qiuyan Wen; Zhizhe Lin; Xuena Wang; Yongwei Gu; Baoyue Ding; Jianming Chen; Xin Wu
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

8.  Validation of an Ex Vivo Permeation Method for the Intestinal Permeability of Different BCS Drugs and Its Correlation with Caco-2 In Vitro Experiments.

Authors:  Aroha B Sánchez; Ana C Calpena; Mireia Mallandrich; Beatriz Clares
Journal:  Pharmaceutics       Date:  2019-11-29       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.